$BNOW ~ One of the key elements driving the rapid adoption of DiOx+ in the medical industry is its effectiveness in eliminating dangerous pathogens and viruses. They are on track to complete their Form-10 Filing and Audit to go SEC Fully Reporting this month, which will coincide with up-listing to the OTCQB. https://finance.yahoo.com/news/boon-industrie...00994.html